Title:
BROMODOMAIN INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2018/068282
Kind Code:
A1
Abstract:
Provided are compounds of formula (I),wherein R 1, Y, X 1, X 2, R 2, R 3, R 4, R 5, R 6 and m have any of the values defined in the specification and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).
Inventors:
BOGDAN ANDREW (US)
FIDANZE STEVEN (US)
MCDANIEL KEITH (US)
PRATT JOHN (US)
WANG LE (US)
FIDANZE STEVEN (US)
MCDANIEL KEITH (US)
PRATT JOHN (US)
WANG LE (US)
Application Number:
PCT/CN2016/102068
Publication Date:
April 19, 2018
Filing Date:
October 14, 2016
Export Citation:
Assignee:
ABBVIE INC (US)
ABBVIE PHARMACEUTICAL TRADING SHANGHAI CO LTD (CN)
ABBVIE PHARMACEUTICAL TRADING SHANGHAI CO LTD (CN)
International Classes:
C07D213/50; A61K31/4412; A61P29/00; A61P31/18; A61P35/00; C07D213/68; C07D237/14; C07D401/04
Foreign References:
| CN104884451A | 2015-09-02 | |||
| CN105164130A | 2015-12-16 | |||
| CN105939996A | 2016-09-14 |
Other References:
See also references of EP 3526197A4
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
Previous Patent: METHOD FOR CULTIVATING PLANT IN TRANSPARENT SEALED CONTAINER AND MEDIUM THEREFOR
Next Patent: BROMODOMAIN INHIBITORS
Next Patent: BROMODOMAIN INHIBITORS